Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Schizophrenia from a neural circuitry perspective: advancing toward rational pharmacological therapies
David A. Lewis, Robert A. Sweet
David A. Lewis, Robert A. Sweet
Published April 1, 2009
Citation Information: J Clin Invest. 2009;119(4):706-716. https://doi.org/10.1172/JCI37335.
View: Text | PDF
Review Series

Schizophrenia from a neural circuitry perspective: advancing toward rational pharmacological therapies

  • Text
  • PDF
Abstract

Schizophrenia is a severe disorder that disrupts the function of multiple brain systems, resulting in impaired social and occupational functioning. The etiology and pathogenesis of schizophrenia appear to involve the interplay of a potentially large number of genetic liabilities and adverse environmental events that disrupt brain developmental pathways. In this Review, we discuss a strategy for determining how particular common and core clinical features of the illness are associated with pathophysiology in certain circuits of the cerebral cortex. The identification of molecular alterations in these circuits is providing critical insights for the rational development of new therapeutic interventions.

Authors

David A. Lewis, Robert A. Sweet

×

Total citations by year

Year: 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 Total
Citations: 4 7 7 11 2 5 6 7 8 6 13 11 10 14 14 5 130
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (130)

Title and authors Publication Year
Nrg1 intracellular signaling regulates the development of interhemispheric callosal axons in mice
Rodríguez-Prieto Á, Mateos-White I, Aníbal-Martínez M, Navarro-González C, Gil-Sanz C, Domínguez-Canterla Y, González-Manteiga A, Del Buey Furió V, López-Bendito G, Fazzari P
Life science alliance 2024
Neural Circuitry-Related Biomarkers for Drug Development in Psychiatry: An Industry Perspective.
O'Donnell P, Buhl DL, Johannesen J, Lijffijt M
Advances in neurobiology 2024
Utilizing Technology to Enhance the Ecological Validity of Cognitive and Functional Assessments in Schizophrenia: An Overview of the State-of-the-Art
Horan WP, Moore RC, Belanger HG, Harvey PD
Schizophrenia Bulletin Open 2024
(Re)building the nervous system: A review of neuron–glia interactions from development to disease
Demmings MD, da Silva Chagas L, Traetta ME, Rodrigues RS, Acutain MF, Barykin E, Datusalia AK, German\u2010Castelan L, Mattera VS, Mazengenya P, Skoug C, Umemori H
Journal of Neurochemistry 2024
Functional connectivity and gray matter deficits within the auditory attention circuit in first-episode psychosis
Curtis MT, Sklar AL, Coffman BA, Salisbury DF
Frontiers in Psychiatry 2023
Beyond the γ-aminobutyric acid hypothesis of schizophrenia
Fujihara K
Frontiers in cellular neuroscience 2023
Morphological and transcriptomic analyses of stem cell-derived cortical neurons reveal mechanisms underlying synaptic dysfunction in schizophrenia.
Kathuria A, Lopez-Lengowski K, Watmuff B, Karmacharya R
Genome Medicine 2023
DiGeorge syndrome critical region gene 2 (DGCR2), a schizophrenia risk gene, regulates dendritic spine development through cell adhesion
Ren D, Luo B, Chen P, Yu L, Xiong M, Fu Z, Zhou T, Chen WB, Fei E
Cell & Bioscience 2023
Human stem cell-based models to study synaptic dysfunction and cognition in schizophrenia: A narrative review.
Santarriaga S, Gerlovin K, Layadi Y, Karmacharya R
Schizophrenia Research 2023
Inflammatory markers in outpatients with schizophrenia diagnosis in regular use of clozapine: a cross-sectional study
Cordova VH, Teixeira AD, Anzolin AP, Moschetta R, Belmonte-de-Abreu PS
Frontiers in Psychiatry 2023
Auditory Cortex Thickness Is Associated With N100 Amplitude in Schizophrenia Spectrum Disorders
Slapø NB, Nerland S, Nordbø Jørgensen K, Mørch-Johnsen L, Pettersen JH, Roelfs D, Parker N, Valstad M, Pentz A, Timpe CM, Richard G, Beck D, Werner MC, Lagerberg TV, Melle I, Agartz I, Westlye LT, Steen NE, Andreassen OA, Moberget T, Elvsåshagen T, Jönsson EG
2023
The Organization of Somatostatin-Immunoreactive Cells in the Visual Cortex of the Gerbil.
Kwon KM, Lee MJ, Chung HS, Pak JH, Jeon CJ
Biomedicines 2022
Assessing the effects of antipsychotic medications on schizophrenia functional analysis: a postmortem proteome study.
Alnafisah RS, Reigle J, Eladawi MA, O'Donovan SM, Funk AJ, Meller J, Mccullumsmith RE, Shukla R
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2022
Overexpression of Neuregulin-1 Type III Has Impact on Visual Function in Mice.
Su N, Zhang W, Eter N, Heiduschka P, Zhang M
International journal of molecular sciences 2022
Alternative Therapy of Psychosis: Potential Phytochemicals and Drug Targets in the Management of Schizophrenia
Saleem A, Qurat-ul-Ain, Akhtar MF
Frontiers in pharmacology 2022
Gadd45 in Neuronal Development, Function, and Injury.
Sultan FA, Sawaya BE
Advances in experimental medicine and biology 2022
Schizophrenia-associated differential DNA methylation in brain is distributed across the genome and annotated to MAD1L1, a locus at which DNA methylation and transcription phenotypes share genetic variation with schizophrenia risk.
McKinney BC, McClain LL, Hensler CM, Wei Y, Klei L, Lewis DA, Devlin B, Wang J, Ding Y, Sweet RA
Translational Psychiatry 2022
Medial Prefrontal Cortex Dysfunction Mediates Working Memory Deficits in Patients With Schizophrenia
Williams JC, Zheng ZJ, Tubiolo PN, Luceno JR, Gil RB, Girgis RR, Slifstein M, Abi-Dargham A, Van Snellenberg JX
2022
Not Just a Bystander: The Emerging Role of Astrocytes and Research Tools in Studying Cognitive Dysfunctions in Schizophrenia
CY Chang, DZ Luo, JC Pei, MC Kuo, YC Hsieh, WS Lai
International journal of molecular sciences 2021
Shedding light on the role of CX3CR1 in the pathogenesis of schizophrenia
K Chamera, M Szuster-Głuszczak, A Basta-Kaim
Pharmacological reports : PR 2021
Directly and Indirectly Targeting the Glycine Modulatory Site to Modulate NMDA Receptor Function to Address Unmet Medical Needs of Patients With Schizophrenia
JC Pei, DZ Luo, SS Gau, CY Chang, WS Lai
Frontiers in Psychiatry 2021
Behavioral Consequences of a Combination of Gad1 Haplodeficiency and Adolescent Exposure to an NMDA Receptor Antagonist in Long-Evans Rats
K Fujihara, T Sato, K Higeta, Y Miyasaka, T Mashimo, Y Yanagawa
Frontiers in pharmacology 2021
Overexpression of neuregulin 1 in GABAergic interneurons results in reversible cortical disinhibition
YY Wang, B Zhao, MM Wu, XL Zheng, L Lin, DM Yin
Nature Communications 2021
Pitch and Duration Mismatch Negativity are Associated With Distinct Auditory Cortex and Inferior Frontal Cortex Volumes in the First-Episode Schizophrenia Spectrum
MT Curtis, BA Coffman, DF Salisbury
2021
Investigating Post-translational Modifications in Neuropsychiatric Disease: The Next Frontier in Human Post-mortem Brain Research
MJ Grubisha, RA Sweet, ML MacDonald
Frontiers in molecular neuroscience 2021
Brain glutamate concentration in men with early psychosis: a magnetic resonance spectroscopy case–control study at 7 T
BR Godlewska, A Minichino, U Emir, I Angelescu, B Lennox, M Micunovic, O Howes, PJ Cowen
Translational Psychiatry 2021
The Engram’s Dark Horse: How Interneurons Regulate State-Dependent Memory Processing and Plasticity
F Raven, SJ Aton
Frontiers in neural circuits 2021
A Kalirin missense mutation enhances dendritic RhoA signaling and leads to regression of cortical dendritic arbors across development
Grubisha MJ, Sun T, Eisenman L, Erickson SL, Chou SY, Helmer CD, Trudgen MT, Ding Y, Homanics GE, Penzes P, Wills ZP, Sweet RA
Proceedings of the National Academy of Sciences 2021
Identification of a Risk Locus at 7p22.3 for Schizophrenia and Bipolar Disorder in East Asian Populations
Li W, Zhang CY, Liu J, Guan F, Shao M, Zhang L, Liu Q, Yang Y, Su X, Zhang Y, Xiao X, Luo XJ, Li M, Lv L
Frontiers in Genetics 2021
Transcriptomic organization of the human brain in post-traumatic stress disorder
MJ Girgenti, J Wang, D Ji, DA Cruz, MB Stein, J Gelernter, KA Young, BR Huber, DE Williamson, MJ Friedman, JH Krystal, H Zhao, RS Duman
Nature Neuroscience 2020
Estradiol reverses excitatory synapse loss in a cellular model of neuropsychiatric disorders
F Erli, AB Palmos, P Raval, J Mukherjee, KJ Sellers, NJ Gatford, SJ Moss, NJ Brandon, P Penzes, DP Srivastava
Translational Psychiatry 2020
Genetic labeling reveals temporal and spatial expression pattern of D2 dopamine receptor in rat forebrain
Q Yu, YZ Liu, YB Zhu, YY Wang, Q Li, DM Yin
Brain structure & function 2019
Density of small dendritic spines and microtubule-associated-protein-2 immunoreactivity in the primary auditory cortex of subjects with schizophrenia
BC McKinney, ML MacDonald, JT Newman, MA Shelton, RA DeGiosio, RM Kelly, KN Fish, AR Sampson, DA Lewis, RA Sweet
Neuropsychopharmacology 2019
Comparative characterization of human induced pluripotent stem cells (hiPSC) derived from patients with schizophrenia and autism
LM Grunwald, R Stock, K Haag, S Buckenmaier, MC Eberle, D Wildgruber, H Storchak, M Kriebel, S Weißgraeber, L Mathew, Y Singh, M Loos, KW Li, U Kraushaar, AJ Fallgatter, H Volkmer
Translational Psychiatry 2019
Prefrontal cortex interneurons display dynamic sex-specific stress-induced transcriptomes
MJ Girgenti, ES Wohleb, S Mehta, S Ghosal, MV Fogaca, RS Duman
Translational Psychiatry 2019
The medial pulvinar: function, origin and association with neurodevelopmental disorders
J HommanLudiye, JA Bourne
Journal of Anatomy 2019
Stereological Assessments of Neuronal Pathology in Auditory Cortex in Schizophrenia
EM Parker, RA Sweet
Frontiers in neuroanatomy 2018
Inference of cell type content from human brain transcriptomic datasets illuminates the effects of age, manner of death, dissection, and psychiatric diagnosis
MH Hagenauer, A Schulmann, JZ Li, MP Vawter, DM Walsh, RC Thompson, CA Turner, WE Bunney, RM Myers, JD Barchas, AF Schatzberg, SJ Watson, H Akil, M Hetman
PloS one 2018
Uncovering Discrete Synaptic Proteomes to Understand Neurological Disorders
YZ Wang, J Savas
Proteomes 2018
Resting-state network connectivity and metastability predict clinical symptoms in schizophrenia
WH Lee, GE Doucet, E Leibu, S Frangou
Schizophrenia Research 2018
Chronic methamphetamine self-administration dysregulates 5-HT2A and mGlu2 receptor expression in the rat prefrontal and perirhinal cortex: Comparison to chronic phencyclidine and MK-801
PU Hámor, J Šírová, T Páleníček, M Zaniewska, V Bubeníková-Valešová, M Schwendt
Pharmacology, biochemistry, and behavior 2018
Stem cell models of human synapse development and degeneration
ES Wilson, K Newell-Litwa, M Bronner
Molecular biology of the cell 2018
DNA methylation as a putative mechanism for reduced dendritic spine density in the superior temporal gyrus of subjects with schizophrenia
B McKinney, Y Ding, DA Lewis, RA Sweet
Translational Psychiatry 2017
MEF2C transcription factor is associated with the genetic and epigenetic risk architecture of schizophrenia and improves cognition in mice
AC Mitchell, B Javidfar, V Pothula, D Ibi, EY Shen, CJ Peter, LK Bicks, T Fehr, Y Jiang, KJ Brennand, RL Neve, J Gonzalez-Maeso, S Akbarian
Molecular Psychiatry 2017
A Novel Bio-Psychosocial-Behavioral Treatment Model in Schizophrenia
YK Kim, J Choi, SC Park
International journal of molecular sciences 2017
Somatostatin-positive GABA Interneuron Deficits in Depression: Cortical Microcircuit and Therapeutic Perspectives
C Fee, M Banasr, E Sibille
Biological Psychiatry 2017
Loudness- and time-dependence of auditory evoked potentials is blunted by the NMDA channel blocker MK-801
T Teichert
Psychiatry Research 2017
The epigenomics of schizophrenia, in the mouse
B Javidfar, R Park, BS Kassim, LK Bicks, S Akbarian
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2017
Genetic disruption of ankyrin-G in adult mouse forebrain causes cortical synapse alteration and behavior reminiscent of bipolar disorder
S Zhu, ZA Cordner, J Xiong, CT Chiu, A Artola, Y Zuo, AD Nelson, TY Kim, N Zaika, BM Woolums, EJ Hess, X Wang, DM Chuang, MM Pletnikov, PM Jenkins, KL Tamashiro, CA Ross
Proceedings of the National Academy of Sciences 2017
Abnormal Complex Auditory Pattern Analysis in Schizophrenia Reflected in an Absent Missing Stimulus Mismatch Negativity
DF Salisbury, AG McCathern
Brain Topography 2016
Reversal of dendritic phenotypes in 16p11.2 microduplication mouse model neurons by pharmacological targeting of a network hub
KD Blizinsky, B Diaz-Castro, MP Forrest, B Schürmann, AP Bach, MD Martin-de-Saavedra, L Wang, JG Csernansky, J Duan, P Penzes
Proceedings of the National Academy of Sciences 2016
Disease signatures for schizophrenia and bipolar disorder using patient-derived induced pluripotent stem cells
B Watmuff, SS Berkovitch, JH Huang, J Iaconelli, S Toffel, R Karmacharya
Molecular and Cellular Neuroscience 2016
Postmortem structural studies of the thalamus in schizophrenia
KA Dorph-Petersen, DA Lewis
Schizophrenia Research 2016
Control of Dendritic Spine Morphological and Functional Plasticity by Small GTPases
KM Woolfrey, DP Srivastava
Neural plasticity 2016
Elevated midline-parietal gamma band noise power in schizophrenia but not in bipolar patients
V Suazo, A Lubeiro, R Jurado-Barba, M Moreno-Ortega, M Dompablo, I Morales-Muñoz, R Rodriguez-Jimenez, T Palomo, V Molina
European Archives of Psychiatry and Clinical Neuroscience 2016
The Novel, Nicotinic Alpha7 Receptor Partial Agonist, BMS-933043, Improves Cognition and Sensory Processing in Preclinical Models of Schizophrenia
LJ Bristow, AE Easton, YW Li, DV Sivarao, R Lidge, KM Jones, D Post-Munson, C Daly, NJ Lodge, L Gallagher, T Molski, R Pieschl, P Chen, A Hendricson, R Westphal, J Cook, C Iwuagwu, D Morgan, Y Benitex, D King, JE Macor, R Zaczek, R Olson, K Hashimoto
PloS one 2016
The role of P2X7 receptors in a rodent PCP-induced schizophrenia model
B Koványi, C Csölle, S Calovi, A Hanuska, E Kató, L Köles, A Bhattacharya, J Haller, B Sperlágh
Scientific Reports 2016
DYRK1A-mediated Cyclin D1 Degradation in Neural Stem Cells Contributes to the Neurogenic Cortical Defects in Down Syndrome
S Najas, J Arranz, PA Lochhead, AL Ashford, D Oxley, JM Delabar, SJ Cook, MJ Barallobre, ML Arbonés
EBioMedicine 2015
Alterations in Cortical Network Oscillations and Parvalbumin Neurons in Schizophrenia
G Gonzalez-Burgos, RY Cho, DA Lewis
Biological Psychiatry 2015
How Schizophrenia Develops: Cognitive and Brain Mechanisms Underlying Onset of Psychosis
TD Cannon
Trends in Cognitive Sciences 2015
Schizophrenia symptom and functional correlates of anterior cingulate cortex activation to emotion stimuli: An fMRI investigation
BD Nelson, OA Bjorkquist, EK Olsen, ES Herbener
Psychiatry Research Neuroimaging 2015
Therapeutic Targets for Neurodevelopmental Disorders Emerging from Animal Models with Perinatal Immune Activation
D Ibi, K Yamada
International journal of molecular sciences 2015
Different Paths to Core Pathology: The Equifinal Model of the Schizophrenia Syndrome: Fig. 1
IW Green, JR Glausier
Schizophrenia Bulletin 2015
Somatic deletions implicated in functional diversity of brain cells of individuals with schizophrenia and unaffected controls
J Kim, JY Shin, JI Kim, JS Seo, MJ Webster, D Lee, S Kim
Scientific Reports 2014
Identification of transcriptional regulatory elements for Ntng1 and Ntng2 genes in mice
K Yaguchi, S Nishimura-Akiyoshi, S Kuroki, T Onodera, S Itohara
Molecular brain 2014
Revitalizing Psychiatric Therapeutics
SE Hyman
Neuropsychopharmacology 2014
Mismatch negativity in recent-onset and chronic schizophrenia: a current source density analysis
WR Fulham, PT Michie, PB Ward, PE Rasser, J Todd, PJ Johnston, PM Thompson, U Schall
PloS one 2014
Identification of Developmentally Regulated PCP-Responsive Non-Coding RNA, prt6, in the Rat Thalamus
H Takebayashi, N Yamamoto, A Umino, T Nishikawa
PloS one 2014
Reduced expression of nogo-a leads to motivational deficits in rats
T Enkel, SM Berger, K Schönig, B Tews, D Bartsch
Frontiers in behavioral neuroscience 2014
A sequence variant in human KALRN impairs protein function and coincides with reduced cortical thickness
TA Russell, KD Blizinsky, DJ Cobia, ME Cahill, Z Xie, RA Sweet, J Duan, PV Gejman, L Wang, JG Csernansky, P Penzes
Nature Communications 2014
Whole genome methylation analyses of schizophrenia patients before and after treatment
B Rukova, R Staneva, S Hadjidekova, G Stamenov, V Milanova, D Toncheva
Biotechnology & Biotechnological Equipment 2014
Developmental exposure to the organochlorine insecticide endosulfan alters expression of proteins associated with neurotransmission in the frontal cortex: Developmental Endosulfan and Frontal Cortex
WW Wilson, W Onyenwe, JM Bradner, SE Nennig, WM Caudle
Synapse 2014
Finding Pieces to the Puzzle of Brain Structure in Schizophrenia
RM Bilder
Biological Psychiatry 2014
Cell autonomous regulation of hippocampal circuitry via Aph1b-γ-secretase/neuregulin 1 signalling
P Fazzari, A Snellinx, V Sabanov, T Ahmed, L Serneels, A Gartner, SA Shariati, D Balschun, BD Strooper, E Kim
eLife 2014
Altered Glutamate Protein Co-Expression Network Topology Linked to Spine Loss in the Auditory Cortex of Schizophrenia
ML MacDonald, Y Ding, J Newman, S Hemby, P Penzes, DA Lewis, NA Yates, RA Sweet
Biological Psychiatry 2014
Dendritic spine alterations in schizophrenia
CE Moyer, MA Shelton, RA Sweet
Neuroscience Letters 2014
Development and specification of GABAergic cortical interneurons
C Kelsom, W Lu
Cell & Bioscience 2013
BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases
B Lu, G Nagappan, X Guan, PJ Nathan, P Wren
Nature Reviews Neuroscience 2013
A High-Resolution Enhancer Atlas of the Developing Telencephalon
A Visel, L Taher, H Girgis, D May, O Golonzhka, RV Hoch, GL McKinsey, K Pattabiraman, SN Silberberg, MJ Blow, DV Hansen, AS Nord, JA Akiyama, A Holt, R Hosseini, S Phouanenavong, I Plajzer-Frick, M Shoukry, V Afzal, T Kaplan, AR Kriegstein, EM Rubin, I Ovcharenko, LA Pennacchio, JL Rubenstein
Cell 2013
Disruption of Anterior Insula Modulation of Large-Scale Brain Networks in Schizophrenia
LV Moran, MA Tagamets, H Sampath, A O’Donnell, EA Stein, P Kochunov, LE Hong
Biological Psychiatry 2013
Alterations to the circuitry of the frontal cortex following exposure to the polybrominated diphenyl ether mixture, DE-71
JM Bradner, TA Suragh, WM Caudle
Toxicology 2013
Cognitive and motivational deficits together with prefrontal oxidative stress in a mouse model for neuropsychiatric illness
AW Johnson, H Jaaro-Peled, N Shahani, TW Sedlak, S Zoubovsky, D Burruss, F Emiliani, A Sawa, M Gallagher
Proceedings of the National Academy of Sciences 2013
Development of Sensory Gamma Oscillations and Cross-Frequency Coupling from Childhood to Early Adulthood
RY Cho, CP Walker, NR Polizzotto, TA Wozny, C Fissell, CM Chen, DA Lewis
Cerebral Cortex 2013
Progress in the Genetics of Polygenic Brain Disorders: Significant New Challenges for Neurobiology
SA McCarroll, SE Hyman
Neuron 2013
Mismatch negativity: translating the potential
J Todd, L Harms, U Schall, PT Michie
Frontiers in Psychiatry 2013
Regulation of spine formation by ErbB4 in PV-positive interneurons
DM Yin, XD Sun, JC Bean, TW Lin, A Sathyamurthy, WC Xiong, TM Gao, YJ Chen, L Mei
The Journal of neuroscience : the official journal of the Society for Neuroscience 2013
Schizophrenia and abnormal brain network hubs
Rubinov M, Bullmore E
Dialogues in clinical neuroscience 2013
Interneuron dysfunction in psychiatric disorders
O Marín
Nature Reviews Neuroscience 2012
NMDA Receptor Hypofunction, Parvalbumin-Positive Neurons and Cortical Gamma Oscillations in Schizophrenia
G Gonzalez-Burgos, DA Lewis
Schizophrenia Bulletin 2012
Is Rational Antipsychotic Polytherapy Feasible? A Selective Review
RA Kroken, E Johnsen
Current Psychiatry Reports 2012
Selective Expression of KCNS3 Potassium Channel α-Subunit in Parvalbumin-Containing GABA Neurons in the Human Prefrontal Cortex
D Georgiev, G González-Burgos, M Kikuchi, Y Minabe, DA Lewis, T Hashimoto
PloS one 2012
Reduced Myelin Basic Protein and Actin-Related Gene Expression in Visual Cortex in Schizophrenia
PR Matthews, SL Eastwood, PJ Harrison
PloS one 2012
Reduced Glutamate Decarboxylase 65 Protein Within Primary Auditory Cortex Inhibitory Boutons in Schizophrenia
CE Moyer, KM Delevich, KN Fish, JK Asafu-Adjei, AR Sampson, KA Dorph-Petersen, DA Lewis, RA Sweet
Biological Psychiatry 2012
The CB(1) cannabinoid receptor drives corticospinal motor neuron differentiation through the Ctip2/Satb2 transcriptional regulation axis
J Díaz-Alonso, T Aguado, CS Wu, J Palazuelos, C Hofmann, P Garcez, F Guillemot, HC Lu, B Lutz, M Guzmán, I Galve-Roperh
The Journal of neuroscience : the official journal of the Society for Neuroscience 2012
Cortical circuit dysfunction and cognitive deficits in schizophrenia--implications for preemptive interventions
DA Lewis
The European journal of neuroscience 2012
Disease and genetic contributions toward local tissue volume disturbances in schizophrenia: a tensor-based morphometry study
Y Yang, KH Nuechterlein, OR Phillips, B Gutman, F Kurth, I Dinov, PM Thompson, RF Asarnow, AW Toga, KL Narr
Human Brain Mapping 2012
Altered Cortical GABA Neurotransmission in Schizophrenia: Insights into Novel Therapeutic Strategies
Stan A, Lewis DA
Current pharmaceutical biotechnology 2012
Epigenetic management of major psychosis
J Peedicayil
Clinical Epigenetics 2011
Sex steroids and schizophrenia
JA Markham
Reviews in Endocrine and Metabolic Disorders 2011
Brain molecular aging, promotion of neurological disease and modulation by Sirtuin5 longevity gene polymorphism
C Glorioso, S Oh, GG Douillard, E Sibille
Neurobiology of Disease 2011
Targeting glutamate synapses in schizophrenia
JR Field, AG Walker, PJ Conn
Trends in Molecular Medicine 2011
Drug targets: single-cell transcriptomics hastens unbiased discovery
T Bartfai, PT Buckley, J Eberwine
Trends in Pharmacological Sciences 2011
Increased expression of Kalirin-9 in the auditory cortex of schizophrenia subjects: Its role in dendritic pathology
AJ Deo, ME Cahill, S Li, I Goldszer, R Henteleff, JE VanLeeuwen, I Rafalovich, R Gao, EK Stachowski, AR Sampson, DA Lewis, P Penzes, RA Sweet
Neurobiology of Disease 2011
Rimonabant for neurocognition in schizophrenia: A 16-week double blind randomized placebo controlled trial
DL Boggs, DL Kelly, RP McMahon, JM Gold, DA Gorelick, J Linthicum, RR Conley, F Liu, J Waltz, MA Huestis, RW Buchanan
Schizophrenia Research 2011
Rapid Estradiol Modulation of Neuronal Connectivity and Its Implications for Disease
DP Srivastava, P Penzes
Frontiers in Endocrinology 2011
α1,6-Fucosyltransferase-deficient Mice Exhibit Multiple Behavioral Abnormalities Associated with a Schizophrenia-like Phenotype
T Fukuda, H Hashimoto, N Okayasu, A Kameyama, H Onogi, O Nakagawasai, T Nakazawa, T Kurosawa, Y Hao, T Isaji, T Tadano, H Narimatsu, N Taniguchi, J Gu
The Journal of biological chemistry 2011
Hippocampal interneurons are abnormal in schizophrenia
C Konradi, CK Yang, EI Zimmerman, KM Lohmann, P Gresch, H Pantazopoulos, S Berretta, S Heckers
Schizophrenia Research 2011
Functional resting-state networks are differentially affected in schizophrenia
ND Woodward, B Rogers, S Heckers
Schizophrenia Research 2011
Trajectory of Cognitive Decline as a Predictor of Psychosis in Early Alzheimer Disease in the Cardiovascular Health Study
JE Emanuel, OL Lopez, PR Houck, JT Becker, EA Weamer, MA Demichele-Sweet, L Kuller, RA Sweet
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2011
Mapping corticocortical structural integrity in schizophrenia and effects of genetic liability
OR Phillips, KH Nuechterlein, RF Asarnow, KA Clark, R Cabeen, Y Yang, RP Woods, AW Toga, KL Narr
Biological Psychiatry 2011
In utero electroporation as a tool for genetic manipulation in vivo to study psychiatric disorders: from genes to circuits and behaviors
Y Taniguchi, T Young-Pearse, A Sawa, A Kamiya
The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry 2011
Altered expression of regulators of the cortical chloride transporters NKCC1 and KCC2 in schizophrenia
D Arion, DA Lewis
Archives of general psychiatry 2010
A Novel Mechanism and Treatment Target for Presynaptic Abnormalities in Specific Striatal Regions in Schizophrenia
VE Barakauskas, CL Beasley, AM Barr, AR Ypsilanti, HY Li, AE Thornton, H Wong, G Rosokilja, JJ Mann, B Mancevski, Z Jakovski, N Davceva, B Ilievski, AJ Dwork, P Falkai, WG Honer
Neuropsychopharmacology 2010
Basal ganglia pathology in schizophrenia: dopamine connections and anomalies
E Perez-Costas, M Melendez-Ferro, RC Roberts
Journal of Neurochemistry 2010
Altered Cortical CDC42 Signaling Pathways in Schizophrenia: Implications for Dendritic Spine Deficits
M Ide, DA Lewis
Biological Psychiatry 2010
Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models
DT Malone, MN Hill, T Rubino
British Journal of Pharmacology 2010
Cannabinoid CB1 Receptor Immunoreactivity in the Prefrontal Cortex: Comparison of Schizophrenia and Major Depressive Disorder
SM Eggan, SR Stoyak, CD Verrico, DA Lewis
Neuropsychopharmacology 2010
Prenatal stress: Role in psychotic and depressive diseases
JA Markham, JI Koenig
Psychopharmacology 2010
Animal models of neuropsychiatric disorders
EJ Nestler, SE Hyman
Nature Neuroscience 2010
ErbB4 in parvalbumin-positive interneurons is critical for neuregulin 1 regulation of long-term potentiation
YJ Chen, M Zhang, DM Yin, L Wen, A Ting, P Wang, YS Lu, XH Zhu, SJ Li, CY Wu, XM Wang, C Lai, WC Xiong, L Mei, TM Gao
Proceedings of the National Academy of Sciences 2010
The chandelier neuron in schizophrenia
DA Lewis
Developmental Neurobiology 2010
Mapping Synaptic Pathology within Cerebral Cortical Circuits in Subjects with Schizophrenia
RA Sweet, KN Fish, DA Lewis
Frontiers in human neuroscience 2010
No association of psychosis in Alzheimer disease with neurodegenerative pathway genes
MA DeMichele-Sweet, L Klei, B Devlin, RE Ferrell, EA Weamer, JE Emanuel, OL Lopez, RA Sweet
Neurobiology of Aging 2010
Epac2-mediated dendritic spine remodeling: implications for disease
P Penzes, KM Woolfrey, DP Srivastava
Molecular and cellular neurosciences 2010
From maps to mechanisms through neuroimaging of schizophrenia
A Meyer-Lindenberg
Nature 2010
Disruptive insights in psychiatry: transforming a clinical discipline
Thomas R. Insel
Journal of Clinical Investigation 2009
Primate models of schizophrenia: future possibilities
AA Simen, R DiLeone, AF Arnsten
Progress in brain research 2009
From the Cover: Identification of functional marker proteins in the mammalian growth cone
M Nozumi, T Togano, K Takahashi-Niki, J Lu, A Honda, M Taoka, T Shinkawa, H Koga, K Takeuchi, T Isobe, M Igarashi
Proceedings of the National Academy of Sciences 2009
Pyramidal neuron number in layer 3 of primary auditory cortex of subjects with schizophrenia
KA Dorph-Petersen, KM Delevich, MJ Marcsisin, W Zhang, AR Sampson, HJ Gundersen, DA Lewis, RA Sweet
Brain Research 2009
Neuroplasticity of excitatory and inhibitory cortical circuits in schizophrenia
Lewis DA
Dialogues in clinical neuroscience 2009

← Previous 1 2 3 4 5 6 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts